Skip to main content
VIDEO CENTER

Clinical Trials

Understanding Your Role in Advancing Cancer Research

Are Clinical Trials Safe? What to Know About Safety, Ethics, and Your Rights

There are many safeguards in place to protect you if you participate in a clinical trial.

Patricia Pinto-Garcia, MD, MPH profile image

Reviewed by Patricia Pinto-Garcia, MD, MPH

Updated on April 30, 2025

If you’re thinking of participating in a clinical trial for cancer treatment, you may wonder if it’s safe or not. There are many safeguards in place to reduce risk as much as possible.

Safeguard #1: The Institutional Review Board, or IRB

The IRB is a committee of independent researchers, clinicians, statisticians, and more. 

“They’re all getting together on a frequent basis to monitor the clinical trials to make sure that the clinical trial plan is safe, that it’s ethical, that the informed consent is as complete as possible, and to make sure that there’s safety protocols in place,” says June Y. Hou, MD, Gynecologic Oncologist at Columbia University’s Irving Medical Center.

Safeguard #2: Informed Consent

Before agreeing to participate, you would sit with the research team to hear about the logistics, possible risks and benefits, and goals of the trial. Then, you may agree to participate and sign the consent form, if you choose.

Safeguard #3: The Four Stages

The stages of a clinical trial are structured to reduce risk to participants

For example, in stage 1, researchers work with a small group of 15 people or so to check for signs of safety. Doctors can monitor these participants very closely to detect and treat issues early. 

After confirming safety, they can move on to later stages with more participants.

Safeguard #4: Data Safety Monitoring Board, or DSMB

Similar to the IRB, the Data Safety Monitoring Board is a committee of independent researchers, statisticians, clinicians, and more. The DSMB usually participates in stage 3 of clinical trials to monitor and review data from the trial. 

The DSMB may end the trial early for safety concerns, or if the trial team has already gotten the answer to their research question.

Safeguard #5: You can leave the trial early

You might choose to leave the trial if the treatment is not working for your cancer, or if you are having “serious or unanticipated side effects,” says Hou. In fact, you can leave the trial for any reason at all.

“There are no financial or legal punitive actions … if they choose to leave a clinical trial early,” says Hou.

Hou adds that if you have any other questions about your rights and safety when participating in a clinical trial, you should reach out to the research team. 

References

ClinicalTrials.gov. (2024). Learn about studies. National Library of Medicine.

Food & Drug Administration. (2025). Institutional Review Boards frequently asked questions

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any information. Please seek medical advice before starting, changing or terminating any medical treatment.